{
    "2019-02-25": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Technician says it's time to fade the biotech rally",
                "features": {
                    "keywords": [
                        "biotech",
                        "rally",
                        "fade"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-16",
                "original_text": "Pharma CEOs to face tough questions about skyrocketing drug prices",
                "features": {
                    "keywords": [
                        "pharma",
                        "CEOs",
                        "drug prices",
                        "skyrocketing"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-17",
                "original_text": "Factbox: Pharma company executives to testify at U.S. Senate drug price hearing",
                "features": {
                    "keywords": [
                        "pharma",
                        "executives",
                        "testify",
                        "Senate",
                        "drug price hearing"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-18",
                "original_text": "Big Pharma to testify in Senate drug pricing hearing",
                "features": {
                    "keywords": [
                        "Big Pharma",
                        "testify",
                        "Senate",
                        "drug pricing"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-03-19",
                "original_text": "The Zacks Analyst Blog Highlights: Merck, Design, Roche and AbbVie",
                "features": {
                    "keywords": [
                        "Zacks",
                        "analyst",
                        "Merck",
                        "Roche",
                        "AbbVie"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2018-03-20",
                "original_text": "Momenta (MNTA) Q4 Loss Narrower Than Expected, Revenues Beat",
                "features": {
                    "keywords": [
                        "Momenta",
                        "Q4",
                        "loss",
                        "narrower",
                        "revenues",
                        "beat"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-21",
                "original_text": "AbbVie Extends Deal With Voyager to Make Parkinson's Drugs",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Voyager",
                        "Parkinson's",
                        "drugs"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-03-22",
                "original_text": "AbbVie to Showcase Scientific Innovation and Research Advancements Across Dermatology Portfolio at 2019 AAD Annual Meeting",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "scientific innovation",
                        "research advancements",
                        "dermatology",
                        "AAD Annual Meeting"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals",
                        "dermatology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}